Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Elderplex Ii 1 X Liquid is a Health Canada–registered human drug (DIN 02234233) held by Bio Active Canada Ltd., containing Glycyrrhiza Glabra. Health Canada lists its status as Cancelled Post Market (status date 15 Sep 2005). Nexara Health has matched 10 registrations of Glycyrrhiza Glabra across 2 other regulated markets.

Health Canada registration

DIN02234233
Brand nameElderplex Ii
Active ingredientGlycyrrhiza Glabra
Strength1 X
Dosage formLiquid
RouteOral
CompanyBio Active Canada Ltd.
StatusCancelled Post Market — 15 Sep 2005
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Glycyrrhiza Glabra registered in other markets

10 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
MalaysiaHimalaya Digestive Wellness CapsulesHimalaya Wellness Malaysia Sdn. Bhd.Natural ProductPRODUCT APPROVEDNPRA
MalaysiaKordel's Estomac Vegetable CapsuleMb Nutraceuticals Sdn BhdNatural ProductPRODUCT APPROVEDNPRA
United StatesGlycyrrhiza GlabraHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesGlycyrrhiza GlabraHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesGlycyrrhiza GlabraHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesGlycyrrhiza GlabraHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesGlycyrrhiza GlabraHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesGlycyrrhiza GlabraHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesGlycyrrhiza GlabraHahnemann Laboratories, INC.PelletlistedFDA NDC
United StatesGlycyrrhiza GlabraBoironPelletlistedFDA NDC

See every manufacturer of Glycyrrhiza Glabra worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Elderplex Ii (DIN 02234233) marketed in Canada?

No. Health Canada lists DIN 02234233 as Cancelled Post Market as of 15 Sep 2005.

Who holds the Canadian licence for this product?

Bio Active Canada Ltd. is the company of record in the Health Canada Drug Product Database.

Is Glycyrrhiza Glabra registered outside Canada?

Yes — Nexara Health has matched 10 registrations in 2 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02234233, status date 2005-09-15; national medicine registries: FDA NDC, NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02234233, status date 2005-09-15; national medicine registries: FDA NDC, NPRA.

Health Canada Drug Product Database (DPD), DIN 02234233, status date 2005-09-15; national medicine registries: FDA NDC, NPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.